Contents1 DLF Q3 Results FY26: Profit Rises 14% as Net Cash Hits ₹11,660 Crore1.1 DLF Q3 Results FY26: Institutional Earnings Overview1.2 DLF Q3 FY26: Key Financial Metrics1.3 DLF Q3 Results FY26: Development Business: Core Earnings Driver1.3.1 New Sales and Booking Activity1.4 DLF Q3 Results FY26: Balance Sheet Transformation: Net Cash Milestone1.5 DLF Q3 Results FY26: … Read more
Contents1 Real Estate Sector Outlook 2026: Housing Cycle, Interest Rates, and Capital Flows1.1 India Real Estate Sector 2026: Institutional Outlook1.2 Real Estate Sector Outlook 2026: Current State of the Indian Real Estate Market1.3 Real Estate Sector Outlook 2026: Key Structural Drivers for the Sector1.3.1 1. Urbanisation and Household Formation1.3.2 2. Premiumisation of Housing Demand1.3.3 3. … Read more
Contents1 L&T Q3 Results FY26: Record ₹1.36 Trillion Orders Drive 31% Core Profit Growth1.1 Quick Answers: L&T Q3 FY261.2 L&T Q3 Results FY26 Earnings Overview1.3 L&T Q3 Results FY26: Consolidated Financial Performance1.4 Record Order Inflows Signal Multi-Year Visibility1.5 L&T Q3 Results FY26: Segment-Wise Performance1.5.1 Infrastructure Projects1.5.2 Energy Projects1.5.3 Hi-Tech Manufacturing1.5.4 IT and Technology Services1.6 Order Book … Read more
Contents1 Hindalco Q3 Results FY26: Profit at ₹2,049 Crore Despite ₹2,610 Crore Exceptional Loss at Novelis1.1 Hindalco Q3 Results FY26: Key Highlights1.2 Hindalco Q3 Results FY26: Quarterly Performance Overview1.3 Understanding Hindalco’s Business Model1.4 Segment-Wise Performance in Hindalco Q3 Results FY261.4.1 1) Novelis Segment1.4.2 2) Aluminium Upstream1.4.3 3) Aluminium Downstream1.4.4 4) Copper Segment1.5 Nine-Month Performance1.6 Exceptional … Read more
Contents1 JSW Steel Q3 Results FY26: Profit at ₹2,410 Crore as Record Volumes Signal Steel Cycle Stabilization1.1 Table of Contents1.2 Key Highlights1.3 JSW Steel Q3 Results FY26: Financial Performance1.4 JSW Steel Q3 Results FY26: Nine-Month Performance1.5 JSW Steel Q3 Results FY26: Volume and Production Trends1.6 Domestic Market Performance1.7 Export Trends1.8 Margin and Cost Analysis1.9 JSW … Read more
Contents1 Coal India Q3 Results FY26: Profit at ₹7,166 Crore as Realizations Weaken and Costs Rise1.1 Table of Contents1.2 Coal India Q3 Results FY26: Key Highlights1.3 Coal India Q3 Results FY26: Financial Performance1.4 Coal India Q3 Results FY26: Nine-Month Performance1.5 Coal India Q3 Results FY26: Margin and Cost Structure1.6 Coal India Q3 Results FY26: Production … Read more
Contents1 ONGC Q3 Results FY26: Profit at ₹8,372 Crore, ₹6.25 Dividend Declared Amid Stable PSU Energy Cycle1.1 Table of Contents1.2 Key Highlights2 ONGC Q3 Results FY26: Financial Performance3 ONGC Q3 Results FY26: Nine-Month Performance Trend3.1 Margin and Cost Structure3.1.1 Key Cost Drivers3.2 Operational Segment Analysis3.2.1 Offshore Operations3.2.2 Onshore Operations3.3 Production and Realization Dynamics3.4 Dividend Policy … Read more
Contents1 Nestlé India Q3 Results FY26: Profit Rises to ₹1,018 Crore on 18.5% Sales Growth1.1 Table of Contents1.2 Nestlé India Q3 Results FY26: Key Highlights1.3 Nestlé India Q3 Results FY26: Financial Performance1.4 Nestlé India Q3 Results FY26: Margin and Cost Structure1.5 Nestlé India Q3 Results FY26: Operational Growth Drivers1.5.1 Nestlé India Q3 Results FY26: Key … Read more
Contents1 Infrastructure Sector: Capex Cycles, Order Books, and Capital Flows1.1 Table of Contents2 Infrastructure Sector: Structure2.1 How Infrastructure Companies Generate Earnings2.2 Government Capex Cycles2.2.1 Capex Expansion Phase2.2.2 Execution Phase2.2.3 Capex Slowdown Phase2.3 Public vs Private Capex2.3.1 Public Capex2.3.2 Private Capex3 Infrastructure Sector: Order Book Dynamics3.1 Execution Cycles and Revenue Recognition3.2 Working Capital Cycles3.3 Balance Sheet … Read more
Contents1 Pharma Sector: Earnings, Specialty Cycles, and Capital Flows1.1 Table of Contents1.2 Pharma Sector: Structure1.2.1 1. Generics Manufacturers1.2.2 2. Specialty Pharma Companies1.2.3 3. India Branded Formulations1.2.4 4. API and Contract Manufacturers1.3 Generics vs Specialty Business Models1.3.1 Generics Business1.3.2 Specialty Business1.4 Pharma Sector: Global Pharma Demand Cycles1.5 Pharma Sector: US Generics Pricing Environment1.6 Pharma Sector: Specialty … Read more